• Molecular NameAlitretinoin
  • Synonymalitretinoin; ALRT-1057; BAL4079; Retinoic Acid
  • Weight300.442
  • Drugbank_IDDB00523
  • ACS_NO5300-03-8
  • Show 3D model
  • LogP (experiment)6.3
  • LogP (predicted, AB/LogP v2.0)5.85
  • pkaN/A
  • LogD (pH=7, predicted)3.26
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.31
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds5
  • TPSA37.3
  • StatusFDA approved
  • AdministrationTopical, oral
  • PharmacologyAn antineoplastic agent developed by Ligand Pharmaceuticals. It is a first generation retinoid.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A